Water content and myelin water fraction in multiple sclerosis

Abstract.Background:Measurements of the T2 decay curve provide estimates of total water content and myelin water fraction in white matter in-vivo, which may help in understanding the pathological progression of multiple sclerosis (MS).Methods:Thirty-three MS patients (24 relapsing remitting, 8 secondary progressive, 1 primary progressive) and 18 controls underwent MR examinations. T2 relaxation data were acquired using a 32-echo measurement. All controls and 18 of the 33 MS patients were scanned in the transverse plane through the genu and splenium of the corpus callosum. Five white matter and 6 grey matter structures were outlined in each of these subjects. The remaining 15 MS patients were scanned in other transverse planes. A total of 189 lesions were outlined in the MS patients. Water content and myelin water fraction were calculated for all regions of interest and all lesions.Results:The normal appearing white matter (NAWM) water content was, on average, 2.2% greater than that from controls, with significant differences occurring in the posterior internal capsules, genu and splenium of the corpus callosum, minor forceps and major forceps (p < 0.0006). On average, MS lesions had 6.3% higher water content than contralateral NAWM (p < 0.0001). Myelin water fraction was 16% lower in NAWM than for controls, with significant differences in the major and minor forceps, internal capsules, and splenium (p < 0.05). The myelin water fraction of MS lesions averaged 52 % that of NAWM.Conclusions:NAWM in MS has a higher water content and lower myelin water fraction than control white matter. The cause of the myelin water fraction decrease in NAWM could potentially be due to either diffuse edema, inflammation, demyelination or any combination of these features. We present a simple model which suggests that myelin loss is the dominant feature of NAWM pathology.

[1]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[2]  W. Tourtellotte,et al.  Some spaces and barriers in postmortem multiple sclerosis. , 1968, Progress in brain research.

[3]  C. Alling,et al.  Lipid alterations in apparently normal white matter in multiple sclerosis. , 1971, Brain research.

[4]  K. Suzuki,et al.  Myelin in multiple sclerosis. Composition of myelin from normal-appearing white matter. , 1973, Archives of neurology.

[5]  W. Norton,et al.  Isolation and Characterization of Myelin , 1977 .

[6]  I. Allen,et al.  A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.

[7]  Y. Itoyama,et al.  Immunocytochemical observations on the distribution of myelin‐associated glycoprotein and myelin basic protein in multiple sclerosis lesions , 1980, Annals of neurology.

[8]  R A Brooks,et al.  Explanation of cerebral white--gray contrast in computed tomography. , 1980, Journal of computer assisted tomography.

[9]  I. Allen,et al.  Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). , 1981, Acta neuropathologica. Supplementum.

[10]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[11]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[12]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[13]  A. Thompson,et al.  Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.

[14]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[15]  A. MacKay,et al.  In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.

[16]  G J Barker,et al.  Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters , 1996, Journal of magnetic resonance imaging : JMRI.

[17]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[18]  A. Mackay,et al.  In vivo measurement of T2 distributions and water contents in normal human brain , 1997, Magnetic resonance in medicine.

[19]  G. Barker,et al.  Nuclear magnetic resonance relaxation in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[20]  W. Brück,et al.  Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions , 1998, Multiple sclerosis.

[21]  A. Marmarou,et al.  Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.

[22]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[23]  B. Rutt,et al.  In vivo measurements of multi-component T2 relaxation behaviour in guinea pig brain. , 1999, Magnetic resonance imaging.

[24]  R. Tarducci,et al.  Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. , 1999, Brain : a journal of neurology.

[25]  Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.

[26]  S. Hauser,et al.  Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.

[27]  M Filippi,et al.  A magnetization transfer histogram study of normal-appearing brain tissue in MS , 2000, Neurology.

[28]  I. Vavasour,et al.  A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain , 2000, Neurology.

[29]  R Stollberger,et al.  Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis , 2000, Magnetic resonance in medicine.

[30]  W. Brück,et al.  Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology , 2000, Glia.

[31]  B K Rutt,et al.  Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS , 2000, Journal of magnetic resonance imaging : JMRI.

[32]  M Cercignani,et al.  A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. , 2000, Archives of neurology.

[33]  P. Matthews,et al.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.

[34]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[35]  I. V. Allen,et al.  Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.

[36]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[37]  G J Barker,et al.  Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions , 2001, Multiple sclerosis.

[38]  G. Comi,et al.  Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.

[39]  L G Nyúl,et al.  Relapsing-remitting Multiple Sclerosis: Fractional Volumetric Analysis of Gray Matter and White Matter , 2000 .

[40]  P M Matthews,et al.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.

[41]  Craig K. Jones,et al.  Normal‐appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T2 , 2002, Magnetic resonance in medicine.

[42]  David H. Miller,et al.  The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis , 2002, Journal of Neurology.

[43]  R. Floris,et al.  Diffusion of water in large demyelinating lesions: a follow-up study , 2002, Neuroradiology.

[44]  Zografos Caramanos,et al.  Magnetization transfer can predict clinical evolution in patients with multiple sclerosis , 2002, Journal of Neurology.

[45]  A. Thompson,et al.  Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis , 2002, Multiple sclerosis.

[46]  J. Mead,et al.  Lipid composition of myelin in multiple sclerosis , 1976, Journal of Neurology.